These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10376124)

  • 1. Effects of continuous exposure to light on behavioral dopaminergic supersensitivity.
    Abílio VC; Freitas FM; Dolnikoff MS; Castrucci AM; Frussa-Filho R
    Biol Psychiatry; 1999 Jun; 45(12):1622-9. PubMed ID: 10376124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of melatonin on behavioral dopaminergic supersensitivity.
    Abílio VC; Vera JA; Ferreira LS; Duarte CR; Martins CR; Torres-Leite D; Ribeiro Rde A; Frussa-Filho R
    Life Sci; 2003 May; 72(26):3003-15. PubMed ID: 12706487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
    Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice.
    Queiroz CM; Alcântara FB; Yagüe AM; Bibancos T; Frussa-Filho R
    Braz J Med Biol Res; 2002 Feb; 35(2):237-42. PubMed ID: 11847528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats.
    Frussa-Filho R; Abílio VC; Bergamo M; Palermo-Neto J
    J Pharm Pharmacol; 1997 Apr; 49(4):412-5. PubMed ID: 9232539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
    Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
    Batool F; Haleem DJ
    Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
    Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
    Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats.
    Diaz R; Fuxe K; Ogren SO
    Neuroscience; 1997 Nov; 81(1):129-40. PubMed ID: 9300406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
    El Hage C; Bédard AM; Samaha AN
    Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide synthesis inhibition attenuates haloperidol-induced supersensitivity.
    Pudiak CM; Bozarth MA
    J Psychiatry Neurosci; 1997 Jan; 22(1):61-4. PubMed ID: 9002394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats.
    Suemaru K; Gomita Y; Furuno K; Araki Y
    Pharmacol Biochem Behav; 1993 Sep; 46(1):135-9. PubMed ID: 7902980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DL-tetrahydropalmatine-produced hypotension and bradycardia in rats through the inhibition of central nervous dopaminergic mechanisms.
    Chueh FY; Hsieh MT; Chen CF; Lin MT
    Pharmacology; 1995 Oct; 51(4):237-44. PubMed ID: 8577817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.